É. Rich

发表

Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies

M. Hudson, M. Fritzler, I. Targoff, 2020, RMD Open.

Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.

M. Mayes, P. Merkel, R. Simms, 2004, Arthritis and rheumatism.

Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.

M. Abrahamowicz, M. Fritzler, M. Koenig, 2008, Arthritis and rheumatism.

Management of Myositis-Related Interstitial Lung Disease.

Joyce S Lee, H. Collard, É. Rich, 2016, Chest.

Atorvastatin-induced necrotizing autoimmune myositis

M. Fritzler, I. Targoff, Y. Robitaille, 2017, Medicine.

Describing and expanding the clinical phenotype of anti-MDA5-associated rapidly progressive interstitial lung disease: case series of nine Canadian patients and literature review

M. Fritzler, I. Targoff, S. Hoa, 2018, Scandinavian journal of rheumatology.

Predicting Mortality in Systemic Sclerosis: Analysis of a Cohort of 309 French Canadian Patients with Emphasis on Features at Diagnosis as Predictive Factors for Survival

É. Rich, J. Goulet, F. Joyal, 2002, Medicine.

Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial.

B. Griffiths, P. Emery, J. Larghero, 2014, JAMA.

Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis

B. Griffiths, P. Emery, J. Larghero, 2014 .

Paucity of radiographic progression in rheumatoid arthritis treated with methotrexate as the first disease modifying antirheumatic drug.

G. Alarcón, L. Moreland, É. Rich, 1999, The Journal of rheumatology.

Living with lupus: a prospective pan-Canadian study.

D. Gladman, J. Esdaile, P. Dobkin, 2001, The Journal of rheumatology.

Redefining Dermatomyositis

J. Raynauld, M. Fritzler, I. Targoff, 2014, Medicine.

Pharmacologic therapy of osteoarthritis

J. Raynauld, J. Pelletier, J. Martel-Pelletier, 1999, Current rheumatology reports.

Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patients

M. Hudson, S. Hussein, J. Raynauld, 2020, Arthritis Research & Therapy.

Thromboembolism complicating the treatment of lupus anticoagulant hypoprothrombinemia syndrome.

É. Vinet, É. Rich, J. Senécal, 2006, The Journal of rheumatology.

Basic Principles in Osteoarthritis Treatment

J. Raynauld, D. Choquette, É. Rich, 1999 .

Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma.

J. Raynauld, L. Lonzetti, D. Choquette, 2001, Arthritis and rheumatism.

Relationship Between Genetic Risk and Age of Diagnosis in Systemic Lupus Erythematosus

D. Gladman, J. Beyene, S. Kamphuis, 2020, The Journal of Rheumatology.

Reactive arthritis in patients attending an urban sexually transmitted diseases clinic.

G. Alarcón, L. Moreland, E. Hook, 1996, Arthritis and rheumatism.

Visually-guided irrigation in patients with early knee osteoarthritis: a multicenter randomized, controlled trial.

K. Kalunian, S. Myers, L. Moreland, 2000, Osteoarthritis and cartilage.

A prospective pilot study investigating the musculoskeletal pain in postmenopausal breast cancer patients receiving aromatase inhibitor therapy.

J. Turgeon, D. Laperrière, S. Mader, 2011, Current oncology.

Counterbalancing patient demands with evidence: Results from a pan-canadian randomized clinical trial of brief supportive-expressive group psychotherapy for women with systemic lupus erythematosus

D. Gladman, J. Esdaile, P. Dobkin, 2002, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

Determinants of health status in fibromyalgia: a comparative study with systemic lupus erythematosus.

P. Dobkin, M. Fitzcharles, D. da Costa, 2000, The Journal of rheumatology.

Quality of life in systemic lupus erythematosus patients during more and less active disease states: differential contributors to mental and physical health.

D. Gladman, J. Esdaile, P. Dobkin, 1999, Arthritis care and research : the official journal of the Arthritis Health Professions Association.

A targeted association study in systemic lupus erythematosus identifies multiple susceptibility alleles

J. Rioux, D. Gladman, P. Fortin, 2011, Genes and Immunity.

Left heart disease: a frequent cause of early pulmonary hypertension in systemic sclerosis, unrelated to elevated NT-proBNP levels or overt cardiac fibrosis but associated with increased levels of MR-proANP and MR-proADM: retrospective analysis of a French Canadian cohort

M. Abrahamowicz, C. Chartrand-Lefebvre, M. Koenig, 2014, Scandinavian journal of rheumatology.

Group psychotherapy reduces illness intrusiveness in systemic lupus erythematosus.

D. Gladman, J. Esdaile, P. Dobkin, 2003, The Journal of rheumatology.

Daratumumab as a rescue therapy in severe refractory anti-SRP immune-mediated necrotising myopathy

O. Landon-Cardinal, É. Rich, H. Chapdelaine, 2023, Annals of the rheumatic diseases.

Lymphocytic alveolitis in a crematorium worker.

É. Rich, T. Schauble, 1994, Chest.

A Prospective Pilot Study Investigating the Nature, the Onset and the Incidence of Joint Pain in Menopausal, Breast Cancer Patients Receiving Aromatase Inhibitor (AI) Therapy.

J. Turgeon, S. Mader, A. Robidoux, 2009 .

Autologous Hematopoietic Stem Cell Transplantation Versus Intravenous Pulse Therapy Cyclophosphamide for Severe or Rapidly Progressive Systemic Sclerosis, the Astis Trial

B. Griffiths, P. Emery, A. Gratwohl, 2012 .

A prospective pilot study investigating the musculoskeletal pain in postmenopausal breast cancer patients receiving aromatase inhibitor therapy.

J. Turgeon, D. Laperrière, S. Mader, 2011, Current oncology.